Efficacy of Exenatide Administered Twice Daily in Body Mass Index Reduction in Patients with Type 2 Diabetes Mellitus

BACKGROUND: Exenatide is a glucagon-like peptide-1 receptor agonist that can reduce body weight. This study aimed to determine the efficacy of exenatide on body mass index (BMI) reduction in patients with type 2 diabetes mellitus (T2DM) with differing baseline body weight, blood glucose, and atheros...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jie, Xian, Tong-Zhang, Teng, Yu, Wang, Xiuzhi, Wu, Ming-Xiao, Li, Chen, Wang, Weihao, Man, Fuli, Zhang, Xianbo, Wang, Xiaoxia, Guo, Li-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199797/
https://www.ncbi.nlm.nih.gov/pubmed/37214201
http://dx.doi.org/10.1155/2022/7128859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199797/
https://www.ncbi.nlm.nih.gov/pubmed/37214201
http://dx.doi.org/10.1155/2022/7128859

Ejemplares similares